通过TRKA信号调节瘤原发性和癌症转移
Yichao Fan1, Boya Zhang1, Xinhui Du1
1Henan Cancer Hospital, Department of Bone and Soft Tissue Cancer, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Current cancer drug targets
|September 6, 2023
概括
热胺受体激酶 (TRK) A通过激活多个信号通路驱动癌症. TRK抑制剂在治疗TRKA驱动的癌症方面表现有前途,即使具有耐药性突变.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 信号传输 信号传输
背景情况:
- 由神经生长因子 (NGF) 激活的热胺受体激酶 (TRK) A是人类癌症的关键驱动因素.
- TRKA过度表达和NTRK1基因融合与瘤发生和癌症进展有关.
- TRKA信号通路 (RAS-MAPK,PI3K-AKT,JAK2-STAT3,PLCγ,Hippo) 调节瘤细胞的增殖,入侵,EMT,PNI,耐药性和癌症疼痛.
研究的目的:
- 审查TRKA在人类癌症中的特征和研究进展.
- 阐明TRKA信号通路在不同瘤类型中的调节作用.
- 总结TRKA作为生物标志物和治疗点的临床意义.
主要方法:
- 对TRKA在癌症中的作用的文献综述.
- 分析TRKA信号通路及其下游效应器.
- 关于TRK抑制剂的临床数据摘要.
主要成果:
- TRKA信号传递对于瘤细胞的增殖,侵袭,上皮细胞-介质细胞过渡 (EMT),围神经侵袭 (PNI),耐药性和癌症疼痛至关重要.
- TRK抑制剂在TRKA过度表达或NTRK1融合的患者中显示出有效性.
- 下一代TRK抑制剂对TRK激酶域突变保持有效性,解决获得的耐药性.
结论:
- 在人类癌症中,TRKA是关键的生物标志物和治疗标.
- 下一代TRK抑制剂对TRKA突变表现出有效性,提供持续的临床益处.
- 了解TRKA的作用为癌症机制和治疗策略提供了新的见解.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Enzyme-linked Receptors
78.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


